MD3073F1 - Method of laryngeal cancer treatment - Google Patents
Method of laryngeal cancer treatmentInfo
- Publication number
- MD3073F1 MD3073F1 MDA20060013A MD20060013A MD3073F1 MD 3073 F1 MD3073 F1 MD 3073F1 MD A20060013 A MDA20060013 A MD A20060013A MD 20060013 A MD20060013 A MD 20060013A MD 3073 F1 MD3073 F1 MD 3073F1
- Authority
- MD
- Moldova
- Prior art keywords
- laryngeal cancer
- cancer treatment
- temperature
- dose
- plasma
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Inventia se refera la medicina, in special la oncologie si poate fi aplicata pentru tratamentul cancerului laringian de gradul I-II. Esenta inventieiconsta in aceea ca se efectueaza laringotomia, criodistructia tumorii cu 1...2 aplicatii cu ajutorul unei sonde cu temperatura agentului criogen de -180°C, apoi se inlatura tesuturile necrotizate cuajutorul unui fascicul de plasma cu temperatura de 2000...3000°C al bisturiului plasmatic, dupa care plaga se sutureaza pe straturi, iar in perioada postoperatorie se efectueaza radioterapia in dozaa cate 2 Gy la o sedinta, in doza totala de 40 Gy la o serie de tratament.The invention relates to medicine, in particular to oncology and may be applied for the treatment of laryngeal cancer of grade I-II. The essence of the invention is that the laryngotomy is performed, the tumor cryodestruction with 1 ... 2 applications using a probe with a cryogenic agent temperature of -180 ° C, then the necrotized tissues are removed with the help of a plasma beam with a temperature of 2000 ... 3000 ° C of the plasma scalpel, after which the wound is sutured on the layers, and during the postoperative period, radiotherapy is performed in the dose of 2 Gy at a session, in the total dose of 40 Gy at a series of treatments.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20060013A MD3071G2 (en) | 2005-12-29 | 2005-12-29 | Method of laryngeal cancer treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20060013A MD3071G2 (en) | 2005-12-29 | 2005-12-29 | Method of laryngeal cancer treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
MD3073F1 true MD3073F1 (en) | 2006-06-30 |
MD3071G2 MD3071G2 (en) | 2007-01-31 |
Family
ID=36643900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20060013A MD3071G2 (en) | 2005-12-29 | 2005-12-29 | Method of laryngeal cancer treatment |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD3071G2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2520253C1 (en) * | 2013-03-27 | 2014-06-20 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации | Method of treating nasopharyngeal tumours |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD3266G2 (en) * | 2006-06-12 | 2007-10-31 | Георге ЦЫБЫРНЭ | Method of surgical treatment of laryngeal carcinoma complicated with respiratory failure |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1439774A1 (en) * | 1986-11-14 | 1990-12-23 | Московский научно-исследовательский онкологический институт им.П.А.Герцена | Method of frontlateral resection of larynx |
SU1823193A1 (en) * | 1990-10-17 | 1995-02-27 | Институт медицинской радиологии АМН СССР | Method for treating larynx carcinoma |
RU2211669C2 (en) * | 2001-09-26 | 2003-09-10 | Российский онкологический научный центр им. Н.Н. Блохина РАМН | Method for treating the cases of generalized laryngeal carcinoma |
-
2005
- 2005-12-29 MD MDA20060013A patent/MD3071G2/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2520253C1 (en) * | 2013-03-27 | 2014-06-20 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации | Method of treating nasopharyngeal tumours |
Also Published As
Publication number | Publication date |
---|---|
MD3071G2 (en) | 2007-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Braunstein et al. | Breast radiation therapy under COVID-19 pandemic resource constraints—approaches to defer or shorten treatment from a comprehensive cancer center in the United States | |
Gianfaldoni et al. | An overview on radiotherapy: from its history to its current applications in dermatology | |
Polistina et al. | Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience | |
Schaue et al. | Opportunities and challenges of radiotherapy for treating cancer | |
CY1120445T1 (en) | COMBINATIONS AND METHODS OF ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY | |
CY1117725T1 (en) | Paclitaxel and Leucomatin Nanoparticles in Combination with Bevasizumab against Cancer | |
CY1106601T1 (en) | USE OF THE QUINAZOLINE DERIVATIVE ZD6474 COMBINED WITH GEMCITABINE AND OPTIONALLY IONIZING RADIATION IN THE TREATMENT OF CANCER | |
NO20066056L (en) | Treatment with Gemcitabine and an EGFR inhibitor | |
NO20066054L (en) | treatment with cisplatin and an EGFR inhibitor | |
BRPI0517075A (en) | use of an epidermal growth factor receptor kinase inhibitor and ionization radiation for cancer treatment | |
Pshenichnov et al. | Comparative study of depth–dose distributions for beams of light and heavy nuclei in tissue-like media | |
BR112018074981A2 (en) | cancer treatments | |
Talik Sisin et al. | Synergetic influence of bismuth oxide nanoparticles, cisplatin and baicalein-rich fraction on reactive oxygen species generation and radiosensitization effects for clinical radiotherapy beams | |
NO20056170L (en) | Cancer combination therapy comprising AZD2171 or ZD1839 | |
Epstein | Is spending on proton beam therapy for cancer going too far, too fast? | |
Roh | The SCAR (Scar Cosmesis Assessment and Rating) scale: new evaluation method for postoperative scars. | |
MD3073F1 (en) | Method of laryngeal cancer treatment | |
Shao et al. | Evidence based analysis of Cisplatin for treating patients with cutaneous squamous cell carcinoma | |
Pötter | Image-guided brachytherapy sets benchmarks in advanced radiotherapy | |
Herman et al. | Radiotherapy using a water bath in the treatment of Bowen’s disease of the digit | |
Kamisawa et al. | Thermo-chemo-radiotherapy for advanced bile duct carcinoma | |
BR112022026094A2 (en) | USES OF A HIF-2A AND LENVATINIB INHIBITOR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND A THERAPEUTIC COMBINATION, AND, KIT | |
Nehlsen et al. | The safety and efficacy of radiation therapy with concurrent dexamethasone, cyclophosphamide, etoposide, and cisplatin-based systemic therapy for multiple myeloma | |
MD3204F1 (en) | Method of laryngeal cancer preoperative treatment | |
Campana et al. | Clinical electrochemotherapy for chest wall recurrence from breast cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent for invention definitely lapsed due to non-payment of fees | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |